| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 Department of Pharmacology, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy
2 Department of Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
3 Department of Drug Sciences, G d’Annunzio University, Chieti, Italy
Correspondence to:
Correspondence to:
Professor P Montuschi, Department of Pharmacology, School of Medicine, Catholic University of the Sacred Heart, L.go F. Vito, 1-00168 Rome, Italy;
pmontuschi{at}rm.unicatt.it
Background: The role of eicosanoids, including leukotrienes (LTs) and prostaglandins (PGs), in chronic obstructive pulmonary disease (COPD) is uncertain. The aim of this study was to investigate whether eicosanoids are measurable in exhaled breath condensate (EBC), a non-invasive method of collecting airway secretions, in patients with stable mild to moderate COPD, and to show possible differences in their concentrations compared with control subjects.
Methods: LTB4, LTE4, PGE2, PGD2-methoxime, PGF2
, and thromboxane B2 (TxB2) were measured in EBC in 15 healthy ex-smokers, 20 steroid naïve patients with COPD who were ex-smokers, and in 25 patients with COPD who were ex-smokers and who were treated with inhaled corticosteroids. The study was of cross sectional design and all subjects were matched for age and smoking habit.
Results: LTB4 and PGE2 concentrations were increased in steroid naïve (LTB4: median 100.6 (range 73.5–145.0) pg/ml, p<0.001; PGE2: 98.0 (range 57.0–128.4) pg/ml, p<0.001) and steroid treated patients with COPD (LTB4: 99.0 (range 57.9–170.5) pg/ml, p<0.001; PGE2: 93.6 (range 52.8–157.0) pg/ml, p<0.001) compared with control subjects (LTB4: 38.1 (range 31.2–53.6) pg/ml; PGE2: 44.3 (range 30.2–52.1) pg/ml). Both groups of patients had similar concentrations of exhaled LTB4 (p=0.43) and PGE2 (p=0.59). When measurable, LTE4 and PGD2-methoxime concentrations were similar in COPD patients and controls, whereas PGF2 concentrations were increased in the former. TxB2-LI was undetectable in any of the subjects.
Conclusions: There is a selective increase in exhaled LTB4 and PGE2 in patients with COPD which may be relatively resistant to inhaled corticosteroid therapy.
Keywords: leukotrienes; prostaglandins; exhaled breath condensate; chronic obstructive pulmonary disease
This article has been cited by other articles:
|
|
 |
|
  G. de Laurentiis, D. Paris, D. Melck, M. Maniscalco, S. Marsico, G. Corso, A. Motta, and M. Sofia Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy Eur. Respir. J., November 1, 2008; 32(5): 1175 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. L. Borrill, K. Roy, and D. Singh Exhaled breath condensate biomarkers in COPD Eur. Respir. J., August 1, 2008; 32(2): 472 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. N'Guessan, B. Temmesfeld-Wollbruck, J. Zahlten, J. Eitel, S. Zabel, B. Schmeck, B. Opitz, S. Hippenstiel, N. Suttorp, and H. Slevogt Moraxella catarrhalis induces ERK- and NF-{kappa}B-dependent COX-2 and prostaglandin E2 in lung epithelium Eur. Respir. J., September 1, 2007; 30(3): 443 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Piotrowski, A. Antczak, J. Marczak, A. Nawrocka, Z. Kurmanowska, and P. Gorski Eicosanoids in Exhaled Breath Condensate and BAL Fluid of Patients With Sarcoidosis Chest, August 1, 2007; 132(2): 589 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lehtonen, P. Oksa, L. Lehtimaki, A. Sepponen, R. Nieminen, H. Kankaanranta, S. Saarelainen, R. Jarvenpaa, J. Uitti, and E. Moilanen Increased alveolar nitric oxide concentration and high levels of leukotriene B4 and 8-isoprostane in exhaled breath condensate in patients with asbestosis Thorax, July 1, 2007; 62(7): 602 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Corhay, L. Hemelaers, M. Henket, J. Sele, and R. Louis Granulocyte Chemotactic Activity in Exhaled Breath Condensate of Healthy Subjects and Patients With COPD Chest, June 1, 2007; 131(6): 1672 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Nana-Sinkam, J. D. Lee, S. Sotto-Santiago, R. S. Stearman, R. L. Keith, Q. Choudhury, C. Cool, J. Parr, M. D. Moore, T. M. Bull, et al. Prostacyclin Prevents Pulmonary Endothelial Cell Apoptosis Induced by Cigarette Smoke Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 676 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Kharitonov and P. J. Barnes Exhaled biomarkers. Chest, November 1, 2006; 130(5): 1541 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Goldbart, J. Krishna, R. C. Li, L. D. Serpero, and D. Gozal Inflammatory Mediators in Exhaled Breath Condensate of Children With Obstructive Sleep Apnea Syndrome. Chest, July 1, 2006; 130(1): 143 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Marian, S. Baraldo, A. Visentin, A. Papi, M. Saetta, L. M. Fabbri, and P. Maestrelli Up-Regulated Membrane and Nuclear Leukotriene B4 Receptors in COPD Chest, June 1, 2006; 129(6): 1523 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Matsuyama, H. Mitsuyama, M. Watanabe, K.-i. Oonakahara, I. Higashimoto, M. Osame, and K. Arimura Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Markers in COPD Chest, December 1, 2005; 128(6): 3817 - 3827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mallia and S. L. Johnston Mechanisms and Experimental Models of Chronic Obstructive Pulmonary Disease Exacerbations Proceedings of the ATS, November 1, 2005; 2(4): 361 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Montuschi, F Macagno, P Parente, S Valente, L Lauriola, G Ciappi, S A Kharitonov, P J Barnes, and G Ciabattoni Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD Thorax, October 1, 2005; 60(10): 827 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Barnes New approaches to COPD Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. D. Gross, J. O. Boyle, J. D. Morrow, M. K. Williams, C. S. Moskowitz, K. Subbaramaiah, A. J. Dannenberg, and A. J. Duffield-Lillico Levels of Prostaglandin E Metabolite, the Major Urinary Metabolite of Prostaglandin E2, Are Increased in Smokers Clin. Cancer Res., August 15, 2005; 11(16): 6087 - 6093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Pons, J. Sauleda, A. Noguera, J. Pons, B. Barcelo, A. Fuster, and A. G. N. Agusti Decreased macrophage release of TGF-{beta} and TIMP-1 in chronic obstructive pulmonary disease Eur. Respir. J., July 1, 2005; 26(1): 60 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Barnes and R. A. Stockley COPD: current therapeutic interventions and future approaches Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Higashimoto, Y. Yamagata, T. Iwata, M. Okada, T. Ishiguchi, H. Sato, M. Masuda, and H. Itoh Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients Eur. Respir. J., May 1, 2005; 25(5): 885 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Baydur Not All That Comes Out Is Hot Air Chest, May 1, 2005; 127(5): 1482 - 1485. [Full Text] [PDF]
|
|
|
|
|
|
K. Kostikas, M. Gaga, G. Papatheodorou, T. Karamanis, D. Orphanidou, and S. Loukides Leukotriene B4 in Exhaled Breath Condensate and Sputum Supernatant in Patients With COPD and Asthma Chest, May 1, 2005; 127(5): 1553 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Santus, A. Sola, P. Carlucci, F. Fumagalli, A. Di Gennaro, M. Mondoni, C. Carnini, S. Centanni, and A. Sala Lipid Peroxidation and 5-Lipoxygenase Activity in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 838 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Barnes Mediators of Chronic Obstructive Pulmonary Disease Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Kharitonov and P. J. Barnes Effects of Corticosteroids on Noninvasive Biomarkers of Inflammation in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 191 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Riccioni, C. Di Ilio, P. Conti, T. C. Theoharides, and N. D'Orazio Advances in Therapy with Antileukotriene Drugs Ann. Clin. Lab. Sci., October 1, 2004; 34(4): 379 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Cap, J Chladek, F Pehal, M Maly, V Petru, P J Barnes, and P Montuschi Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients Thorax, June 1, 2004; 59(6): 465 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Moloney, S. E. Mumby, R. Gajdocsi, J. H. Cranshaw, S. A. Kharitonov, G. J. Quinlan, and M. J. Griffiths Exhaled Breath Condensate Detects Markers of Pulmonary Inflammation after Cardiothoracic Surgery Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 64 - 69. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
